Pulmonary complications after surgery – ANZICS CTG podcast with Ianthe Boden

It's a significant problem, and there are things we can do to prevent them.

But you might be surprised by the solution, and how impressive the effect is.  In fact, if physiotherapists were a drug, they'd be worth billions.

Ianthe Boden joins me to chat about the impact of preoperative physiotherapy on high risk surgical patients on this fantastic podcast


Do buffered solutions make a difference? Simon Finfer is hoping to find out…

It's fair to say that Simon Finfer has had a rather large impact on ICU research in the past couple of decades.

A key member of the original ANZICS Clinical Trials Group, principle investigator for several major trials and the father of this particular meeting, first convened nearly 20 years ago.

In this interview from the CTG Noosa meeting, Simon chats about the upcoming PLUS trial, looking for evidence that buffered fluids for resuscitation of ICU patients improves outcomes compared with normal saline.

Here's the podcast




A question of timing – early versus delayed initiation of renal replacement in ICU

In this, the tenth podcast from the 19th ANZICS CTG meeting in Noosa, Dr Sean Bagshaw discusses his new project, STARRT AKI.

This study is similar in many ways to the tracheostomy timing question.  By initiating RRT early, can we prevent some of the complications developing, thereby improving outcomes?  Or will we just subject patients to an ultimately unhelpful therapy with the attendant consequences?

The truth, hopefully, will be found at the ENND.

Here's the podcast!




Long term outcomes for ICU patients – TEAM and PREDICT with Carol Hodgson

ICU practice, until recently, has been built on its ability to defy nature and keep a dying patient alive.

But as our specialty matures, we're increasingly aware of the impact critical illness has on survivors.  Research is now focussing on these impacts, and sometimes the news is not good.  Our patients suffer greatly in the years after critical illness, with many never returning to the level of function they once had.

Sadly, this burden is often invisible to us, as (unlike most of our colleagues) we often don't see our patients again once they leave the ICU.

Carol Hodgson joins me on this podcast to chat about two important studies that aim to shed further light on this area - TEAM and PREDICT.